Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Consumers Are Willing To Pay More For Specialty Meds, Express Scripts Finds

Executive Summary

An Express Scripts analysis found that consumers are potentially willing to pay more for specialty drugs

You may also be interested in...



Specialty Rx Coverage Should Focus On Appropriate Use, Not Cost Sharing

Focusing on methods to ensure appropriate use may be more effective in controlling spending on specialty pharmaceuticals than prior authorization and cost sharing strategies, a series of articles in the September/October issue of Health Affairs suggest

Specialty Rx Coverage Should Focus On Appropriate Use, Not Cost Sharing

Focusing on methods to ensure appropriate use may be more effective in controlling spending on specialty pharmaceuticals than prior authorization and cost sharing strategies, a series of articles in the September/October issue of Health Affairs suggest

Cost Containment For Specialty Products Is New Horizon For PBMs

Rising spending on specialty pharmaceuticals is creating a major business opportunity for pharmacy benefit managers, despite the sector's historical cost containment challenges

UsernamePublicRestriction

Register

LL1134044

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel